xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma

Journal of Gastroenterology

Volumn 49, Issue 5, 2014, Pages 853-863

  Shiozaki, Atsushi ^a   Iitaka, Daisuke ^a   Ichikawa, Daisuke ^a   Nakashima, Shingo ^a   Fujiwara, Hitoshi ^a   Okamoto, Kazuma ^a   Kubota, Takeshi ^a   Komatsu, Shuhei ^a   Kosuga, Toshiyuki ^a   Takeshita, Hiroki ^a   Shimizu, Hiroki ^a   Nako, Yoshito ^a   Sasagawa, Hisami ^a   Kishimoto, Mitsuo ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cell cycle; Esophageal cancer; xCT SLC7A11

Indexed keywords

AMINO ACID TRANSPORTER; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN; SMALL INTERFERING RNA; TP53INP1 PROTEIN; TRANSCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG; XCT; SLC7A11 PROTEIN, HUMAN;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DOWN REGULATION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; G1 PHASE CELL CYCLE CHECKPOINT; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; WESTERN BLOTTING; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEM Y+; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROARRAY ANALYSIS; PROGNOSIS; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84901453436     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0847-5     Document Type: Article

References (28)

1. Sato H, Tamba M, Ishii T, Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999;274:11455-8.
2. Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal. 2000;2:665-71. (Pubitemid 32062317)
3. Lo M, Wang YZ, Gout PW. The x(c)- cystine/glutamate anti-porter: a potential target for therapy of cancer and other diseases. J Cell Physiol. 2008;215:593-602. (Pubitemid 351632680)
4. Kim JY, Kanai Y, Chairoungdua A, Cha SH, Matsuo H, Kim DK, et al. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta. 2001;1512:335-44. (Pubitemid 32530781)
5. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci. 2005;25:7101-10. (Pubitemid 41113926)
6. Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, Martín R, et al. Identification and characterisation of human xCT that coexpresses, with 4F2 heavy chain, the amino acid transport activity system xc-. Pflugers Arch. 2001;442:286-96. (Pubitemid 32476650)
7. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res. 2003;23:4571-9. (Pubitemid 38173869)
8. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, et al. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate. 2007;67:162-71. (Pubitemid 46185319)
9. Okuno S, Sato H, Kuriyama-Matsumura K, Tamba M, Wang H, Sohda S, et al. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer. 2003;88:951-6. (Pubitemid 36520886)
10. Lo M, Ling V, Low C, Wang YZ, Gout PW. Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Curr Oncol. 2010;17:9-16.
11. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19:387-400.
12. Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene. 2009;28:599-609.
13. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res. 2007;67:9463-71. (Pubitemid 47535936)
14. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol. 1993;119:441-9. (Pubitemid 23165049)
15. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992;69:277-84.
16. Sobin L, Gospodarowicz M, Wittekind C, editors. TNM Classification of malignant tumors. 7th ed. Hoboken: Wiley; 2009.
17. Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia. 2001;15:1633-40. (Pubitemid 32994684)
18. Lastro M, Kourtidis A, Farley K, Conklin DS. xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal. 2008;20:390-9.
19. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal. 2009;11:59-98.
20. Lukas J, Bartkova J, Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol. 1996;16:6917-25. (Pubitemid 26389751)
21. Komatsu S, Imoto I, Tsuda H, Kozaki KI, Muramatsu T, Shimada Y, et al. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis. 2009;30:1139-46.
22. Islas S, Vega J, Ponce L, González-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res. 2002;274:138-48.
23. Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA. 1996;93:10779-84. (Pubitemid 26333066)
24. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115:1765-76. (Pubitemid 40979715)
25. La Thangue NB, Rigby PW. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell. 1987;49:507-13.
26. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245-62. (Pubitemid 28371346)
27. Umemura S, Shirane M, Takekoshi S, Kusakabe T, Itoh J, Egashira N, et al. Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Br J Cancer. 2009;100:764-71.
28. Peters CJ, Rees JR, Hardwick RH, Hardwick JS, Vowler SL, Ong CA, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group, et al. A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology. 2010;139(1995-2004):e15.